Actively Recruiting
Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
Led by RenJi Hospital · Updated on 2025-09-02
104
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
Sponsors
R
RenJi Hospital
Lead Sponsor
S
Shanghai Pulmonary Hospital, Shanghai, China
Collaborating Sponsor
AI-Summary
What this Trial Is About
This multicenter, open label, double-arm study aims at investigating the the continuous effect of long-Term rehabilitation training on clinical improvement(ITTCI) and cardiopulmonary function in pulmonary arterial hypertension patients
CONDITIONS
Official Title
Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with pre-capillary pulmonary arterial hypertension confirmed by right heart catheterization (mPAP 20 mmHg, PVR > 2 Woods unit, PAWP 15 mmHg).
- Patients classified as WHO functional class I to III.
- Age between 18 and 75 years.
- Female patients who are not pregnant.
- Patients treated with targeted PAH drugs and in a stable condition without disease progression.
- Patients who have not undergone exercise rehabilitation training within the past six months.
You will not qualify if you...
- Patients with pulmonary vascular occlusive disease.
- Patients with respiratory diseases.
- Patients with ischemic heart disease, complex congenital heart disease, cardiomyopathy, or valvular disease.
- Patients with active liver disease.
- Patients with severe kidney disease.
- Patients with motor disorders such as lower limb fractures or ataxia.
- Patients with malignant tumors.
- Patients with physical disabilities.
- Patients with hemoglobin levels 2 g/L or less.
- Patients with systolic blood pressure 85 mmHg or less.
- Patients with a history of syncope within 3 months.
- Patients with a history of supraventricular or ventricular arrhythmia at rest within 3 months.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Renji Hospital
Shanghai, Shanghai Municipality, China, 210007
Actively Recruiting
Research Team
J
Jieyan Shen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here